Certolizumab pegol in treatment of Crohn's disease with perianal lesions
- Authors: Khalif IL1, Nanaeva BA1, Shapina MV1, Vardanyan AV1
-
Affiliations:
- A.N. Ryzhikh State Scientific Centre of Coloproctology Ministry of Health of Russia
- Issue: Vol 90, No 4 (2018)
- Pages: 50-54
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32462
- ID: 32462
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
I L Khalif
A.N. Ryzhikh State Scientific Centre of Coloproctology Ministry of Health of Russiaр мед. наук, проф., руководитель отд. по изучению воспалительных заболеваний кишечника Moscow, Russia
B A Nanaeva
A.N. Ryzhikh State Scientific Centre of Coloproctology Ministry of Health of Russia
Email: nanaeva1987@mail.ru
к.м.н., н.с. отд. по изучению воспалительных и функциональных заболеваний кишечника Moscow, Russia
M V Shapina
A.N. Ryzhikh State Scientific Centre of Coloproctology Ministry of Health of Russiaк.м.н., с.н.с. отд. по изучению воспалительных и функциональных заболеваний кишечника Moscow, Russia
A V Vardanyan
A.N. Ryzhikh State Scientific Centre of Coloproctology Ministry of Health of Russiaк.м.н., н.с. отд. хирургии ободочной кишки Moscow, Russia
References
- Felley C, Mottet C, Juillerat P, et al. Fistulizing Crohn’s disease. Digestion. 2007;76:109-12. doi: 10.1159/000111024
- Schwartz D.A, Loftus E.V. Jr, Tremaine W.J, et al. The history of fistulizing Crohn’s disease of Olmsted Country, Minnesota. Gastroenterology. 2002;122:875-80. doi: 10.1053/gast.2002.32362
- Kamm M.A, Ng S.C. Perianal fistulizing Crohn’s disease: a call to action. Clin Gastroenterol Hepatol. 2008;6:7-10. doi: 10.1016/j.cgh. 2007.10.010
- Никулина И.В., Златкина А.Р., Белоусова Е.А. и др. Оценка клинико - эпидемиологических показателей воспалительных заболеваний кишечника в Московской области. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 1997;(2):67-71
- Sandborn W, Fazio V, Feagan B, et al. AGA technical review on perianal Crohn’s disease. Gastroenterology. 2003;125(5):1508-30. doi: 10.1016/j.gastro.2003.08.025
- Neilsen O.H, Rogler G, Hahnloser D, Thomsen O.O. Diagnosis and management of fistulizing Crohn’s disease. Nat Clin Pract Gastroenterol Hepatol. 2009;6:92-106. doi: 10.1038/ncpgasthep1340
- Шелыгин Ю.А., Жарков E.E., Орлова Л.П. и др. Отдаленные результаты иссечения анальной трещины в сочетании с боковой подкожной сфинктеротомией. В кн.: Актуальные проблемы колопроктологии. Москва; 2005. С.141-2
- Judge T.A, Lichtenstein G.R. Treatment of fistulizing Crohn’s disease. Gastroenterol Clin North Аm. 2004;33:421-54. doi: 10.1016/j.gtc. 2004.03.002
- Wilkins T, Jarvis К, Patel J. Diagnosis and management of Crohn’s disease. Am Family Phys. 2011;84:1365-75.
- Thia K.T, Mahadevan U, Feagan B.G, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn’s disease: a randomized, double - blind, placebo - controlled pilot study. Inflam Bowel Dis. 2009;15:17-24. doi: 10.1002/ibd.20608
- Person D.C, May G.R, Fick G.H, Sutherland L.R. Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta - analysis. Ann Inter Med. 1995;123:132-42. doi: 10.7326/0003-4819-123-2-199507150-00009
- Behm B.W, Bickston S.J. Tumor necrosis factor - alpha antibody for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. doi: 10.1002/14651858.CD006893
- Peyrin-Biroulet L, Deltenre P, de Suray N, et al. Efficacy and safety of tumor necrosis factor antagonists in Crohn’s disease meta - analysis of placebo - controlled trials. Clin Gastroenterol Hepatol. 2008;6:644-53. doi: 10.1016/j.cgh.2008.03.014
- Schreiber S, Lawrance I, Thomson O, et al. Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo - controlled study. Aliment Pharmacol Ther. 2011 Jan;33(2):185-93. doi: 10.1111/j.1365-2036.2010.04509.x
- Vavricka S, Schoepfer A, Bansky G, et al. Efficacy and safety of Certolizumab pegol in an unselected Crohn’s disease opulation: 26-week data of the FACTS II survey. Inflamm Bowel Dis. 2011;17(7): 1530-9. doi: 10.1002/ibd.21521
- Lennard-Jons J. Classification of inflammatory bowel disease. Scand J Gastroenerol. 2007;42:576-82.
- Pikarsky A, Gervaz Р, Wexner S. Perianal Crohn disease: a new scoring system tevaluate and predict outcome of surgical intervention. Arch Surg. 2002;137:774-8. doi: 10.1001/archsurg.137.7.774